User profiles for Erlina Burhan
 | Erlina BurhanUniversitas Indonesia Verified email at ui.ac.id Cited by 5367 |
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
…, SMB Gutierrez, J Bruchfeld, E Burhan… - European …, 2015 - Eur Respiratory Soc
Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …
Corona virus disease 2019
…, DR Hadi, F Isbaniah, E Burhan… - Jurnal Respirologi …, 2020 - jurnalrespirologi.org
Corona virus disease 2019 (COVID-19) is a new name given by World Health Organization (WHO)
of 2019 novel corona virus infection, reported at the end of 2019 from Wuhan, Cina. …
of 2019 novel corona virus infection, reported at the end of 2019 from Wuhan, Cina. …
[HTML][HTML] Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study
Background Data on COVID-19-related mortality and associated factors from low-resource
settings are scarce. This study examined clinical characteristics and factors associated with in-…
settings are scarce. This study examined clinical characteristics and factors associated with in-…
Clinical progression of COVID-19 patient with extended incubation period, delayed RT-PCR time-to-positivity, and potential role of chest CT-scan
Coronavirus Disease 2019 (COVID-19), previously called 2019-nCoV, is a novel disease
caused by SARS-CoV-2 which was first identified as outbreak of unknown respiratory illness in …
caused by SARS-CoV-2 which was first identified as outbreak of unknown respiratory illness in …
Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients
Numerous studies have reported low concentrations of antituberculosis drugs in tuberculosis
(TB) patients, but few studies have examined whether low drug concentrations affect TB …
(TB) patients, but few studies have examined whether low drug concentrations affect TB …
A living WHO guideline on drugs for covid-19
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published as …
earlier versions (available as data supplements). New recommendations will be published as …
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: a randomized controlled trial
… Erlina Burhan , Erlina Burhan … Ismail Hadisoebroto Dilogo, Dita Aditianingsih, Adhrie
Sugiarto, Erlina Burhan, Triya Damayanti, Pompini Agustina Sitompul, Nina Mariana, Radiana D. …
Sugiarto, Erlina Burhan, Triya Damayanti, Pompini Agustina Sitompul, Nina Mariana, Radiana D. …
[HTML][HTML] Treatment strategy for rifampin-susceptible tuberculosis
NI Paton, C Cousins, C Suresh, E Burhan… - … England Journal of …, 2023 - Mass Medical Soc
Background Tuberculosis is usually treated with a 6-month rifampin-based regimen.
Whether a strategy involving shorter initial treatment may lead to similar outcomes is unclear. …
Whether a strategy involving shorter initial treatment may lead to similar outcomes is unclear. …
[HTML][HTML] A living WHO guideline on drugs for covid-19
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published as …
earlier versions (available as data supplements). New recommendations will be published as …
[HTML][HTML] Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adults
Background Adjunctive glucocorticoids are widely used to treat human immunodeficiency
virus (HIV)–associated tuberculous meningitis despite limited data supporting their safety and …
virus (HIV)–associated tuberculous meningitis despite limited data supporting their safety and …
